IndraLab

Statements

USP20 deubiquitinates IL1B. 1 / 1

| 1

reach

"USP20 reduces atherogenic signaling in smooth muscle cells by deubiquitinating RIPK1 (receptor interacting serine/threonine kinase 1) in response to TNF (tumor necrosis factor) and IL1B (interleukin 1 beta) stimulation [51]."

38705724

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP20 deubiquitinates IL1B. 1 / 1

INDRA sources:

Databases

Reading